Streetbeat News

Equity Actions

GFS

Analysts have varying opinions on GLOBALFOUNDRIES (NASDAQ:GFS), with recent ratings ranging from bullish to bearish. Over the last quarter, there were 4 somewhat bullish and 1 indifferent rating. The average 12-month price target is now $68.6, down from $75.00, with a high estimate of $75.00 and a low of $65.00. Analysts from firms like Cantor Fitzgerald, B of A Securities, Morgan Stanley, JP Morgan, and Susquehanna have adjusted their price targets and ratings, reflecting changes in market conditions and company performance. GLOBALFOUNDRIES, a semiconductor manufacturer, faces challenges with a -10.7% revenue decline, below-average net margin, ROE, and ROA, but has a conservative debt-to-equity ratio of 0.25.

Portfolio Pulse from Benzinga Insights

January 23, 2024 | 12:01 pm

PWSC

PowerSchool Holdings (NYSE:PWSC) has been rated by 4 analysts in the last three months, with 3 somewhat bullish and 1 indifferent rating. The average 12-month price target is $27.5, up 3.77% from the previous $26.50. Analysts from Piper Sandler, UBS, RBC Capital, and Cantor Fitzgerald have provided recent evaluations, with price targets ranging from $25 to $30. PowerSchool Holdings is a cloud-based software provider for K-12 education, with a market cap below industry average, revenue growth of 12.15%, and strong profitability indicators like net margin, ROE, and ROA. Its debt-to-equity ratio is 0.66, indicating a sound financial structure.

Portfolio Pulse from Benzinga Insights

January 23, 2024 | 12:00 pm

BNTX

BioNTech (NASDAQ:BNTX) has received mixed analyst ratings over the past three months, with 5 analysts offering diverse perspectives. The average 12-month price target is now $116.6, down from $132.25, with a high estimate of $133.00 and a low of $99.00. Analysts from firms including HC Wainwright & Co., JP Morgan, and Morgan Stanley have adjusted their ratings and price targets, reflecting changes in market dynamics and company performance. BioNTech's financial performance shows a significant revenue decline of -74.13% over a 3-month period, but strong net margin and ROE/ROA figures. The company's debt-to-equity ratio is low at 0.01, indicating a conservative debt management approach.

Portfolio Pulse from Benzinga Insights

January 23, 2024 | 12:00 pm

ADM

AGRI

ELAB

WBUY

The article highlights four consumer staples sector stocks considered oversold based on their Relative Strength Index (RSI) values, suggesting potential buying opportunities. Archer-Daniels-Midland Company (ADM) is dealing with internal changes and a significant stock price drop. Webuy Global Ltd (WBUY) announced a strategic collaboration with Ohmyhome. AgriFORCE Growing Systems Ltd. (AGRI) experienced a stock decline following a filing for a stock offering. Elevai Labs, Inc. (ELAB) entered into a license agreement with INmune Bio, Inc. and saw a substantial share price decrease.

Portfolio Pulse from Avi Kapoor

January 23, 2024 | 11:39 am

AMD

ARKB

ARKW

NVDA

Cathie Wood's Ark Investment Management sold shares of Nvidia (NVDA) and AMD (AMD) from its Ark Next Generation Internet ETF (ARKW) ahead of Q4 results. The sales generated approximately $2.39 million from NVDA and $4.11 million from AMD. Analysts remain optimistic, with KeyBanc maintaining Overweight ratings and high price targets for both stocks. Ark's sales may indicate profit-taking or a shift towards undervalued AI stocks or its own ARKB ETF.

Portfolio Pulse from Shanthi Rexaline

January 23, 2024 | 11:35 am

BABA

TCEHY

Richard Fontaine, CEO of the Center for a New American Security, argues that despite China's economic slowdown, demographic challenges, and real estate turmoil, the country still offers significant investment opportunities. China's economy outpaced the U.S. last year and leads in technologies like AI and quantum computing. The Chinese military is expanding, and there's no sign of economic struggles impacting its global activities. However, China's tech giants Alibaba (BABA) and Tencent (TCEHY) face economic headwinds, with reduced external investments and a global tourism hit of $129 billion due to post-pandemic pullback.

Portfolio Pulse from Benzinga Neuro

January 23, 2024 | 10:40 am

BP

BP is expected to appoint Kate Thomson as its permanent Chief Financial Officer (CFO) in the coming weeks, according to sources cited by Reuters.

Portfolio Pulse from Charles Gross

January 23, 2024 | 10:04 am

ACET

Adicet Bio has priced a public offering of 27,054,667 common shares at $2.40 per share and pre-funded warrants for 8,445,333 common shares at $2.3999 each. The expected gross proceeds are approximately $85.2 million, before underwriting discounts, commissions, and expenses. The offering is anticipated to close around January 25, 2024, subject to standard closing conditions.

Portfolio Pulse from Benzinga Newsdesk

January 23, 2024 | 7:18 am

PSBD

Palmer Square Capital BDC has completed its initial public offering (IPO), offering 5.45 million common shares at a price of $16.45 per share. The shares began trading on the New York Stock Exchange on January 18, 2024, under the ticker symbol 'PSBD'. The company raised approximately $89.7 million in gross proceeds, which will be used to make investments aligned with its investment objectives and strategies.

Portfolio Pulse from Benzinga Newsdesk

January 23, 2024 | 7:10 am

BRO

Brown & Brown, Inc. has restructured its business segments from four to three - Retail, Programs, and Wholesale Brokerage - following the divestiture of some businesses within its Services segment in Q4 2023. The change will be effective from 2024.

Portfolio Pulse from Benzinga Newsdesk

January 23, 2024 | 5:59 am